VieCure key facts
as of Oct 2026- Operator of a comprehensive cancer care AI platform intended to empower people to live healthy lives.
- VieCure is valued at approximately $90.0M as of Oct 2026 (last reported valuation).
- It has raised $113.0M; the latest was Later Stage VC ($43.0M) in Nov 2025.
- Notable investors include Socium Ventures, Durable Capital Partners, Sator Grove Holdings, Mitchell Rales, Northpond Ventures.
- Status: Privately Held (backing).
VieCure's last reported valuation, Mar 2021. Nothing priced has surfaced since.
- ·Watch VieCure: the Monday email on marks, rounds and moves
VieCure funding rounds
No funding rounds for VieCure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
VieCure valuation
VieCure's last reported valuation was $90 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.
VieCure investors
5 investors are on record for VieCure, including Socium Ventures, Durable Capital Partners, Sator Grove Holdings and Mitchell Rales.
About VieCure
Operator of a comprehensive cancer care AI platform intended to empower people to live healthy lives. The company's platform utilizes artificial intelligence that helps generate patient-specific treatment plans in real-time for oncologists and patients, enabling healthcare professionals with clinical quality care and to help patients embrace life.
- Sector
- Healthcare
- HQ
- Greenwood Village, CO, United States
- Founded
- 2015
- Employees
- 97
- Website
- viecure.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.